Literature DB >> 18536057

Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Boris Blechacz1, Gregory J Gores.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18536057      PMCID： PMC2547491          DOI： 10.1002/hep.22310

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  208 in total

1.  mir-29 regulates Mcl-1 protein expression and apoptosis.

Authors:  J L Mott; S Kobayashi; S F Bronk; G J Gores
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

Review 2.  Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.

Authors:  Theodora Voskoglou-Nomikos; Joseph L Pater; Lesley Seymour
Journal:  Clin Cancer Res       Date:  2003-09-15       Impact factor: 12.531

Review 3.  Intrahepatic cholangiocarcinoma: indication for transplantation.

Authors:  Andreas Pascher; Sven Jonas; Peter Neuhaus
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

4.  Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study.

Authors:  Marianne E J Ortner; Karel Caca; Frieder Berr; Jochen Liebetruth; Ulrich Mansmann; Dominik Huster; Winfried Voderholzer; Guido Schachschal; Joachim Mössner; Herbert Lochs
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

5.  18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.

Authors:  Carlos U Corvera; Leslie H Blumgart; Timothy Akhurst; Ronald P DeMatteo; Michael D'Angelica; Yuman Fong; William Robert Jarnagin
Journal:  J Am Coll Surg       Date:  2007-10-01       Impact factor: 6.113

6.  Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest.

Authors:  Chang Han; Jing Leng; A Jake Demetris; Tong Wu
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

7.  EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma.

Authors:  Ferga C Gleeson; Elizabeth Rajan; Michael J Levy; Jonathan E Clain; Mark D Topazian; Gavin C Harewood; Georgios I Papachristou; Naoki Takahashi; Charles B Rosen; Gregory J Gores
Journal:  Gastrointest Endosc       Date:  2007-12-03       Impact factor: 9.427

8.  Grasp or brush for biliary sampling at endoscopic retrograde cholangiography? A blinded randomized controlled trial.

Authors:  Jean-Marc Dumonceau; Carlos Macias Gomez; Claudia Casco; Muriel Genevay; Mariano Marcolongo; Massimo Bongiovanni; Philippe Morel; Pietro Majno; Antoine Hadengue
Journal:  Am J Gastroenterol       Date:  2007-09-25       Impact factor: 10.864

9.  A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines.

Authors:  Alphonse E Sirica; Zichen Zhang; Guan-Hua Lai; Toru Asano; Xue-Ning Shen; Deanna J Ward; Arvind Mahatme; Jennifer L Dewitt
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

10.  Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.

Authors:  Takaharu Nakajima; Tetsuji Takayama; Koji Miyanishi; Atsushi Nobuoka; Tsuyoshi Hayashi; Tomoyuki Abe; Junji Kato; Kiyoyuki Sakon; Yoshimitsu Naniwa; Hirohumi Tanabe; Yoshiro Niitsu
Journal:  J Pharmacol Exp Ther       Date:  2003-06-12       Impact factor: 4.030
View more
  259 in total

1.  Targeting PDGFR-β in Cholangiocarcinoma.

Authors:  Christian D Fingas; Joachim C Mertens; Nataliya Razumilava; Steven F Bronk; Alphonse E Sirica; Gregory J Gores
Journal:  Liver Int       Date:  2011-12-02       Impact factor: 5.828

2.  Prostate apoptosis response-4 is expressed in normal cholangiocytes, is down-regulated in human cholangiocarcinoma, and promotes apoptosis of neoplastic cholangiocytes when induced pharmacologically.

Authors:  Antonio Franchitto; Alessia Torrice; Rossella Semeraro; Cristina Napoli; Gennaro Nuzzo; Felice Giuliante; Gianfranco Alpini; Guido Carpino; Pasquale Bartolomeo Berloco; Luciano Izzo; Antonio Bolognese; Paolo Onori; Anastasia Renzi; Alfredo Cantafora; Eugenio Gaudio; Domenico Alvaro
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

3.  Effect of contrast-enhanced ultrasound on differential diagnosis of intrahepatic cholangiocarcinoma and arterial phase enhanced hepatic inflammatory lesions.

Authors:  Shanshan Yin; Qiuli Cui; Kun Yan; Wei Yang; Wei Wu; Liping Bao; Minhua Chen
Journal:  Chin J Cancer Res       Date:  2017-06       Impact factor: 5.087

Review 4.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

Review 5.  Obesity and cholangiocarcinoma.

Authors:  Mansour A Parsi
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

Review 6.  Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma.

Authors:  Hiroaki Haga; Irene Yan; Kenji Takahashi; Joseph Wood; Tushar Patel
Journal:  Gene Expr       Date:  2014

7.  A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.

Authors:  Amy L Collins; Sylwia Wojcik; James Liu; Wendy L Frankel; Hansjuerg Alder; Lianbo Yu; Thomas D Schmittgen; Carlo M Croce; Mark Bloomston
Journal:  Ann Surg Oncol       Date:  2013-09-18       Impact factor: 5.344

8.  Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma.

Authors:  Zhao-Ru Dong; Chi Zhang; Jia-Bin Cai; Peng-Fei Zhang; Guo-Ming Shi; Dong-Mei Gao; Hui-Chuan Sun; Shuang-Jian Qiu; Jian Zhou; Ai-Wu Ke; Jia Fan
Journal:  Tumour Biol       Date:  2014-12-06

9.  MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.

Authors:  Florin M Selaru; Alexandru V Olaru; Takatsugu Kan; Stefan David; Yulan Cheng; Yuriko Mori; Jian Yang; Bogdan Paun; Zhe Jin; Rachana Agarwal; James P Hamilton; John Abraham; Christos Georgiades; Hector Alvarez; Perumal Vivekanandan; Wayne Yu; Anirban Maitra; Michael Torbenson; Paul J Thuluvath; Gregory J Gores; Nicholas F LaRusso; Ralph Hruban; Stephen J Meltzer
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

10.  Cholangiocarcinoma: expanding the spectrum of risk factors.

Authors:  Diaa H Elfaki; Andrea A Gossard; Keith D Lindor
Journal:  J Gastrointest Cancer       Date:  2009-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.